MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$118,376K
Net Income
-$35,067K
Net Profit Margin
-29.62%
EPS
-$0.56
Unit: Thousand (K) dollars
Revenue Breakdown
Americas
EMEA
Asia Pacific
Revenue Breakdown
Ngs Tools
Antibody Discovery
Revenue Breakdown
Diagnostics
Industrial Chemicals
Academic Research
Others
Revenue Breakdown
Selling, general and administrat...
Cost of revenues
Stock-based compensation expense
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
118,376
110,715
103,698
99,009
Cost of revenues
55,922
53,593
49,726
48,172
Research and development expenses
18,025
19,695
17,130
17,014
Selling, general and administrative expenses
80,709
76,085
69,742
63,758
Restructuring and other costs
-
-
-
0*
Change in fair value of contingent considerations and holdbacks
-
-
-
0*
Impairment of long-lived assets
-
-
-
0*
Litigation settlement costs, net of recoveries
0
7,205
-
-
Total costs and expenses
154,656
156,578
136,598
128,944
Loss from operations
-36,280
-45,863
-32,900
-29,935
Loss on sale of business
0
-
-
167
Interest income
1,500
1,710
2,175
2,633
Other income (expense), net
40
175
471
253
Income (loss) before income taxes
-34,740
-43,978
-30,254
-26,882
Income tax expense
311
43
253
253
Net (loss) income
-35,051
-44,021
-30,507
-27,138
Change in unrealized loss (gain) on investments
-41
-85
18
11
Foreign currency translation adjustment
25
17
38
208
Comprehensive (loss) income
-35,067
-44,089
-30,451
-26,919
Basic EPS
-0.56
-0.71
-0.5
-0.445
Diluted EPS
-0.56
-0.71
-0.5
-0.454
Basic Average Shares
62,403,000
61,702,000
61,080,000
60,426,000
Diluted Average Shares
62,403,000
61,702,000
61,080,000
59,257,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
4
Comprehensive (loss) income
-$35,067K
(-273.70%↓ Y/Y)
Foreign currency
translation adjustment
$25K
(114.12%↑ Y/Y)
Net (loss) income
-$35,051K
(-271.90%↓ Y/Y)
Change in unrealized
loss (gain) on...
-$41K
(-64.00%↓ Y/Y)
Income (loss) before
income taxes
-$34,740K
(-268.80%↓ Y/Y)
Income tax expense
$311K
(62.83%↑ Y/Y)
Interest income
$1,500K
(-44.24%↓ Y/Y)
Other income
(expense), net
$40K
(104.78%↑ Y/Y)
Americas
$77,259K
(30.09%↑ Y/Y)
EMEA
$33,622K
(9.37%↑ Y/Y)
Asia Pacific
$7,495K
(26.43%↑ Y/Y)
Loss from operations
-$36,280K
(-20.45%↓ Y/Y)
Revenues
$118,376K
(23.24%↑ Y/Y)
Total costs and
expenses
$154,656K
(22.57%↑ Y/Y)
Selling, general and
administrative expenses
$80,709K
(27.36%↑ Y/Y)
Cost of revenues
$55,922K
(24.94%↑ Y/Y)
Research and development
expenses
$18,025K
(-0.12%↓ Y/Y)
Buy us a coffee
Twist Bioscience Corp (TWST)
Twist Bioscience Corp (TWST)